PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test
Test Name: PITX3 Gene Anterior segment mesenchymal dysgenesis Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test gene PITX3
Test Details
The PITX3 gene is a gene that encodes for a protein called Pituitary homeobox 3, which is involved in the development of various tissues and organs, including the eye. Anterior segment mesenchymal dysgenesis (ASMD) is a rare genetic disorder characterized by abnormal development of the front part of the eye, including the cornea, iris, and lens.
NGS, or next-generation sequencing, is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of genetic testing for ASMD, NGS can be used to analyze the PITX3 gene for any disease-causing mutations or variations.
A genetic test for PITX3 gene mutations using NGS can help diagnose ASMD in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of ASMD or for prenatal testing in families with a known PITX3 gene mutation.
By identifying specific mutations in the PITX3 gene, NGS genetic testing can provide valuable information for genetic counseling, management, and potentially targeted treatments for individuals with ASMD.
Test Name | PITX3 Gene Anterior segment mesenchymal dysgenesis Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test gene PITX3 |
Test Details |
The PITX3 gene is a gene that encodes for a protein called Pituitary homeobox 3, which is involved in the development of various tissues and organs, including the eye. Anterior segment mesenchymal dysgenesis (ASMD) is a rare genetic disorder characterized by abnormal development of the front part of the eye, including the cornea, iris, and lens. NGS, or next-generation sequencing, is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of genetic testing for ASMD, NGS can be used to analyze the PITX3 gene for any disease-causing mutations or variations. A genetic test for PITX3 gene mutations using NGS can help diagnose ASMD in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of ASMD or for prenatal testing in families with a known PITX3 gene mutation. By identifying specific mutations in the PITX3 gene, NGS genetic testing can provide valuable information for genetic counseling, management, and potentially targeted treatments for individuals with ASMD. |